Literature DB >> 33159418

Role of exosome in autoimmunity, with a particular emphasis on rheumatoid arthritis.

Alireza Hejrati1, Bahare Hasani2,3, Mozhgan Esmaili2,3, Davood Bashash4, Naeimeh Tavakolinia5, Parisa Zafari2,3.   

Abstract

Cell-derived exosomes are identified as carriers of lipids, proteins, and genetic materials that participate in cell-cell signal communication, biological process, and cell signaling. Also, their involvement has been reported in a vast array of disorders and inflammatory conditions such as autoimmune diseases. Rheumatoid arthritis (RA), a common cause of joint disorder, is an inflammation-based disease in which the precise understanding of its pathogenesis needs to be further investigated. Also, there is only a palliative care approach for the alleviation of RA symptoms. This paper discusses the recent advances in the biology of exosomes in autoimmune disorders especially in RA, and also provides a new line of research for arthritis therapy using exosomes.
© 2020 Asia Pacific League of Associations for Rheumatology and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  autoimmunity; exosome; rheumatoid arthritis; rheumatologic disorders

Year:  2020        PMID: 33159418     DOI: 10.1111/1756-185X.14021

Source DB:  PubMed          Journal:  Int J Rheum Dis        ISSN: 1756-1841            Impact factor:   2.454


  4 in total

Review 1.  The roles and therapeutic approaches of MSC-derived exosomes in colorectal cancer.

Authors:  Jie Yang; Liman Zhang
Journal:  Clin Transl Oncol       Date:  2022-01-17       Impact factor: 3.405

Review 2.  Circulating extracellular vesicles and rheumatoid arthritis: a proteomic analysis.

Authors:  Mohammed Alghamdi; Sultan Abdulmughni Alamry; Sami M Bahlas; Vladimir N Uversky; Elrashdy M Redwan
Journal:  Cell Mol Life Sci       Date:  2021-12-31       Impact factor: 9.261

Review 3.  Colorectal cancer-derived exosomes and modulation KRAS signaling.

Authors:  Yan Hua Wan; Qi Sheng Liu; Sha Sha Wan; Ri Wei Wang
Journal:  Clin Transl Oncol       Date:  2022-07-05       Impact factor: 3.340

Review 4.  Osteopontin in autoimmune disorders: current knowledge and future perspective.

Authors:  Canhua Xu; Yaohong Wu; Ning Liu
Journal:  Inflammopharmacology       Date:  2022-03-02       Impact factor: 5.093

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.